Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
News
Insured Cancer Patients Continue to Face Barriers To Medically Necessary Treatment, New Report Warns
The new report published by The Leukemia & Lymphoma Society and Manatt Health offers concrete policy solutions.
Research
Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009
WALTHAM, Mass., January 4, 2023 – Immunitas Therapeutics (“Immunitas”), a clinical stage precision immunotherapy company committed to discovering and …
Research
Apply to the Influential Medicine Providing Access to Clinical Trials (IMPACT) Program
Expanding access to high-quality clinical trials to patients served by community health settings, particularly rural, minority, and/or economically di…
Research
Ryvu Therapeutics Announces Closing of Equity Offering with Gross Proceeds Over PLN 250 Million ($57M USD)
Krakow, Poland – December 22, 2022 – Ryvu Therapeutics [WSE:RVU], a clinical-stage drug discovery and development company focusing on novel small mole…
News
FDA Approves the First-in-Class Bispecific Antibody for Treatment of Follicular Lymphoma
“This new treatment has the potential to help patients with this hard-to-treat cancer achieve remission,” says LLS Chief Scientific Officer Dr. Lee Gr…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
